Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025
Q2 FY21 results · Jul–Sep 2020
Advanced Enzyme Technologies reported revenue from operations of ₹120.39 crore (up 8.0% from Q2 FY20) and net profit of ₹38.56 crore (up 21.1% from Q2 FY20) for Q2 FY21 (Jul–Sep 2020), on a consolidated basis.
| Item | Q2 FY21 | Q2 FY20 | YoY | Q1 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 120.39 | 111.44 | +8.0% | 110.50 | +8.9% |
| Other income | 0.58 | 1.54 | −62.1% | 5.23 | −88.9% |
| Total income | 120.97 | 112.98 | +7.1% | 115.73 | +4.5% |
| Profit before tax | 51.91 | 41.60 | +24.8% | 49.78 | +4.3% |
| Net profit for the period | 38.56 | 31.84 | +21.1% | 34.80 | +10.8% |
| EPS, basic (₹) | 3.33 | 2.77 | +20.2% | 3.07 | +8.5% |
| Net margin (%) | 32.0 | 28.6 | 31.5 |
| Item | Q2 FY21 | Q2 FY20 | YoY | Q1 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 72.31 | 58.91 | +22.8% | 61.41 | +17.8% |
| Other income | 1.74 | 1.10 | +57.4% | 0.73 | +138.1% |
| Total income | 74.05 | 60.01 | +23.4% | 62.13 | +19.2% |
| Profit before tax | 28.21 | 14.26 | +97.8% | 21.73 | +29.8% |
| Net profit for the period | 20.13 | 11.15 | +80.6% | 15.32 | +31.4% |
| EPS, basic (₹) | 1.80 | 1.00 | +80.0% | 1.37 | +31.4% |
| Net margin (%) | 27.8 | 18.9 | 25.0 |
Consolidated
- Filed with BSE
- 13 Nov 2020, 16:01 IST
- Board meeting
- 12 Nov 2020
- Period
- 01 Jul 2020 to 30 Sep 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 Nov 2020, 16:01 IST
- Board meeting
- 12 Nov 2020
- Period
- 01 Jul 2020 to 30 Sep 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE